1,25-Dihydroxyvitamin D, [1, 25(OH),D,] induces differentiation and inhibits proliferation of myeloid leukemic cells from various lines and patients; these effects are probably mediated through the 1,25(OH),D, receptor. Little is known of expression of 1,25(OH),D, receptor RNA in hematopoietic cells. We examined the expression and modulation of expression of 1,25(OH),D, receptor RNA in various proliferating and nonproliferating hematopoietic cells. Constitutive expression of 1,25(OH),D, receptor RNA was detected in various kinds of hematopoietic cells, including macrophages and activated T lymphocytes, as well as in cell lines KG-1 (myeloblasts), HL-60 (promyelocytes), ML-3 (myelomonoblasts), U937, THP-1 (monoblasts), K562 (erythroblasts), and S-LB1 (HTLV-1-transfected T lymphocytes). Receptor transcripts were 4.6 kilobases (kb), and no variant sizes were observed. , which is the active form, principally involved in calcium homeostasis.14 The 1,25(OH),D, facilitates calcium absorption from the intestine, acts to mobilize calcium from bone, and stimulates renal reabsorption of calcium. Studies suggest that this active metabolite may also play an important role as an immunohematopoietic regulatory h o r m~n e .~.~ The 1,25(OH),D, can induce cells from both the murine myeloid leukemia line (M-1)6 and the human promyelocytic leukemia line (HL-60)7'9 to differentiate to monocyte/macrophagelike cells. We previously suggested that differentiation induced by 1,25(OH),D3 is mediated through the intracellular 1,25(OH),D3 receptor.8 The receptor is an intracellular polypeptide that selectively binds 1,25(OH),D3 with high 
receptor and its RNA were examined. Levels of RNA coding for the receptor were not modulated by exposure t o high levels of ligand. Levels of occupied 1,25(OH),D, receptor protein increased in these HL-60 cells; but the total number of 1,25(OH),D, receptors decreased about 50% at 24 hours and returned toward normal at 72 hours. Steady-state levels of 1,25(OH),D, receptor RNA were not affected by terminal differentiation of HL-60 toward either granulocytes or macrophages. Nondividing macrophages from normal individuals also expressed 1,25(OH) affinity and interacts with hormone-sensitive genes to produce a biologic effect.','0,'' Recently, cDNA clones encoding chicken, rat, and human 1,25(OH),D, receptors were isolated and characterized as members of the steroidhhyroid hormone receptor
In this study, we analyzed the range of expression of RNA coding for 1,25(OH),D, receptor in various normal and leukemic hematopoietic cells. In addition, we determined basic characteristics of 1,25(OH),D, receptor RNA in hematopoietic cells. Comparison of 1,25(OH),D3 receptor number to 1,25(OH),D, receptor RNA was made in several experiments.
MATERIALS AND METHODS

Cells.
Avariety of human hematopoietic cells was examined for expression of RNA coding for 1,25(OH),D, receptor. Leukemia cell lines used in this study were as follows: KG-1 (myeloblasts), HL-60 (promyelocytes), ML-3 (early myelomonoblasts), THP-1 and U937 (monoblasts), K562 (early myeloidlerythroid blast cells), and S-LB1 (T-lymphoid line immortalized by human T cell leukemia virus type I HTLV-1).I5 B-lymphocyte lines were as follows: Daudi (human Burkitt's lymphoma cells), Dutko (hybrid cell line between Daudi and K562 cells that contains the full complement of both parental chromosomes), Plant (human B-lymphoma cells), Jiyoye (human Burkitt's lymphoma cells), CBL-3 [Epstein-Barr virus (EBV)-positive B-cell line established from human cord blood lymphocytes cultured with MOLT 4f supernatant in serum-free medium], HCLL-7876 (hairy cell leukemia B cells), and BV173 (B lymphocytes from a patient with lymphoid blast crisis of chronic myelogenous leukemia).16 Plant cells were established in our laboratory. CBL-3 and HCLL-7876 cells were gifts from Dr C. Uittenbogaart (UCLA, Los Angeles, CA.); Daudi and Dutko cells were a gift from Dr G. Klein (Stockholm, Sweden). Lu-CSF-1 is a cell line of human adenocarcinoma of lung.I7 Cells were cultured in a-medium (Flow Laboratories, Rockville, MD) supplemented with 10% fetal bovine serum (FBS, Irvine Scientific, Santa Ana, CA) in a humidified atmosphere with 5% CO,.
1.25-DIHYDROXYVITAMIN D, RECEPTOR RNA
Mononuclear blood cells were isolated by Ficoll-Hypaque (Pharmacia, Piscataway, NJ) density separation from heparinized venous blood obtained from healthy donors after they gave informed consent. These cells were washed several times with phosphatebuffered saline (PBS). Macrophages were removed by their ability to adhere by culturing cells on plastic dishes for 3 hours. The nonadherent mononuclear fraction contained > 90% lymphocytes, as determined by light microscopy of Wright-Giemsa-stained slide preparations. The adherent cells were > 95% macrophages as determined by morphologic examination using light microscopy of Wright-Giemsa-stained slides and by positive staining with a-naphtyl butyrate esterase.
Induction of differentiation was measured both by morphology of Giemsa-stained cytospin preparations and by nitroblue tetrazolium (NBT).' For NBT, cell suspension (2 X lo' cells/mL) was mixed with an equal volume of solution containing 1.25 mg/mL NBT (Sigma Chemical, St Louis, MO), 17 mg/mL bovine albumin and 1 mg/mL 12-0-tetradecanoylphorbol13-acetate (TPA) (Sigma) for 30 minutes at 37°C. The cells were washed in PBS, cytocentrifuged, fixed in methanol, and stained with safranin for 10 minutes.
The 1,25(OH),D3, provided by Dr M. Uskokovic (Hoffman-La Roche, Nutley, NJ) was dissolved in 100% ethanol to a stock concentration of lo-' m o m and stored at -20°C; the final test concentration was lo-' mol/L. None of the cultures contained >0.1% ethanol, which had no effect on either cellular growth or differentiation. All-trans-retinoic acid (RA) (Sigma) was dissolved in ethanol (lo-' mol/L), stored at -2O"C, and protected from light; the final test concentrations were mom. Dimethylsulfoxide (DMSO, Sigma) was used at a final concentration of 1.25%. TPA was dissolved in 100% acetone to a stock concentration of lO-'mol/L, stored at -7o"C, and tested at a final concentration of lo-' mol/L. HL-60 cells can differentiate terminally along the granulocytic pathway''; after 4 days of exposure to either DMSO (1.25%) or RA (lo-' mol/L), -70% and 80%, respectively, of the HL-60 cells matured toward granulocytelike cells, as shown by morphology and ability to reduce NBT. HL-60 cells also can differentiate along the macrophage pathwaP9; exposure to either 1,25(OH),D, (lo-' m o m ) or TPA (lo-' m o m ) for 4 days induced -85% and 95%, respectively, of HL-60 cells to differentiate toward morphologic and functional macrophage-like cells, as measured by positive staining with a-naphtyl butyrate esterase. Actinomycin D (Boehringer Mannheim) was dissolved in 100% ethanol to a stock concentration of 1 mg/mL. Cycloheximide (CHX) was purchased from Sigma. Recombinant human tumor necrosis factor-a (TNF-a) (5.6 x lo7 U/mg protein) and recombinant lymphotoxin (LT) (2 x 108 U/mg protein) were supplied by Genentech (South San Francisco, Dr M. Shepard). Specific activity of each was assayed by examining cytolytic activity on actinomycin D-treated L929 fibroblasts."
Total cellular RNA was extracted from hematopoietic cell lines by hot phenol extraction?' Cytoplasmic RNA of lymphocytes was isolated by phenol-chloroform extraction?' Poly-A' RNA was obtained by oligo-dT cellulose chromatography. Thirty micrograms total cellular RNA or 3 pg poly-A' RNA were electrophoresed on formaldehyde-agarose gels (Bethesda Research Laboratories, Gaithersberg, MD), and transferred to nylon membranes (ICN Biomedicals, Irvine, CA). The labeled probes were hybridized for 16 to 24 hours at 42°C in 50% fomamide, 2 X SSC (1 X SSC = 150 mmol/L NaCI, 15 mmol/L sodium citrate, pH 7.0), 5 x Denhardt's, 0.1% sodium dodecyl sulfate (SDS), and 10% dextran sulfate (Sigma). Filters were washed to stringency of 0.1 x SSC at 65°C and exposed to Kodak XAR film. Autoradiograms were exposed for 24 hours to 7 days. Modulation in levels of 1,25(OH),D, receptor RNA was quantified by initial standardization to the amount of P-actin-specific tranChemicals and cellular differentiation.
RNA isolation and blotting.
scripts. The relative density of p-actin-specific and 1,25(OH),D, receptor-specific transcripts in the different lanes was first determined by laser densitometry using multiple exposures of blots, and the ratio of 1,25(OH),D, receptor@-actin in the control lane was assigned as the baseline level. The fold-stimulation in the experimental lanes was calculated by multiplying the ratio of density of (1,25(OHXD, receptor/@-actin) transcripts by the reciprocal of the ratio of the baseline level.
A human 1,25(OH),D, receptor cDNA probe (EcoRI-PstI, 1.1 kb) was purified from plasmid pGEM-7Zf(+) (a gift from Dr J.W. Pike).', The p-actin probe was EcoRI-BamHI (0.7 kb) fragment from plasmid pHF A-3'ut." These probes were "P-labeled by random ~r i m i n g ?~ To examine stability of RNA coding for 1,25(OH),D3 receptor, total RNA was extracted from S-LB1 cells that were exposed to actinomycin D (5 pg/mL) for 0.25 to 8 hours. Actinomycin D at 5 pg/mL blocked >95% total RNA synthesis in S-LB1 cells, as measured by l4C-uridine incorporation (data not shown). Cell viability was more than 90% throughout these experiments, as determined by trypan blue exclusion.
To determine the role of new protein synthesis in regulation of RNA coding for levels of 1,25(OH),D3 receptor, the cells were treated with 20 pg/mL CHX, a protein synthesis inhibitor. Protein synthesis in cells cultured with CHX was less than 10% of that of untreated cells (data not shown).
For saturation analysis, cells were harvested by centrifugation and washed twice in normal saline. Cells were then homogenized in a glass Teflon Potter- For receptor quantitation, an exchange assay was performed. After treatment with lo-' mol/L 1,25(OH),D, for the indicated time, cells were harvested and homogenized as for saturation analysis. Each sample was assayed for occupied and unoccupied 1,25(OH),D, receptors as described in detail previously. 26 Cellular incorporation of radioactive thymidine, undine, and methionine. HL-60 cells or either normal human peripheral blood lymphocytes or macrophages were incubated with 1 pCi of either 'H-thymidine, 14C-uridine, or 100 pCi " S-methionine for 4 hours at 37°C; cells were washed twice in PBS. Cellular RNA, DNA, and protein were precipitated in 5% trichloroacetic acid (TCA, 30 mmol/L Na,HPO,) at 4°C for 1 hour, filtered onto glass microfilter membranes (Whatman, Hillsborg, OR), washed in 3% TCA (30 mmoVL Na,HPO,), and heated at 80°C for 1 hour. Radioactivity was counted in a liquid scintillation counter. the same blot with a 32P-labeled p-actin DNA probe demonstrated that comparable amounts of RNA were present in each line (Fig lA, bottom panel) . Further experiments showed that levels of 1,25(OH),D3 receptor RNA were comparable in wild-type HG60 cells as compared with those differentiated toward either granulocytes or macrophages (described in the Materials and Methods section) (data not shown). These terminally differentiated granulocyte-or macrophage-like HG60 cells had an 80% to 95% lower level of 3H-thymidine incorporation as compared with the wild-type HL-60 cells (data not shown). of 1,25(OH),D3 receptor RNA (Fig 1A) . Hybridization of
1,25(0H)p, receptor binding assays.
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were cultured with molL 1,25(OH),D3 for various durations (0 to 72 hours); levels of 1,25(OH),D3 receptor RNA and protein were analyzed by Northern blot (Fig 2A) and receptor binding assays (Fig 2B) . DNA synthesis was analyzed by 'H-thymidine incorporation (Fig 2C) . DNA synthesis began to decrease at 24-hour exposure of 1,25(OH),D3; at 72 hours, DNA synthesis was about one sixth of wild-type HL-60 cells. Levels of expression of 1,25(OH),D3 receptor RNA were not modulated by either short (1 hour) or long (72 hour) exposure of these cells to ligand, however, indicating that 1,25(OH),D3 had no effect on expression of the 1,25(OH),D3 receptor RNA, and expression appeared to be independent of cell division.
To analyze modulation of this receptor after the cells We showed that macrophages constitutively expressed 1,25(OH),D3 receptor RNA and exposure to either TNF-a (10' U h L ) or LT (10, U/mL) for 8 hours did not change levels of expression of 1,25(OH),D3 receptor RNA ( Fig  3A) . These cytokines did stimulate accumulation of M-CSF RNA (data not shown). Macrophages had very little 'Hthymidine incorporation as compared with actively dividing cells (HL-60) and levels of 3H-thymidine incorporation did not change during exposure to either TNF-a or LT ( Fig   3B) .
Expression of 1,25(0H),D, receptor RNA parallels cellular proliferation in lymphocytes.
Most peripheral blood lymphocytes are in the resting stage in the peripheral blood. Many can be stimulated to proliferate after exposure to a mitogen. Levels of expression of 1,25(OH),D, receptor RNA and synthesis of DNA as measured by ,H-thymidine incorporation were examined in normal human peripheral blood lymphocytes stimulated by 0.5% phytohemagglutinin (PHA) for different durations (0 to 72 hours). 'H-Thymidine incorporation increased in a time-dependent fashion; after exposure to PHA for 24 hours, it was 10.5-fold above baseline; at 48 and 72 hours, it was 36.5-and 50-fold greater, respectively, as compared with the unstimulated lymphocytes (Fig 4B) . Resting lymphocytes expressed very low levels of 1,25(OH),D, receptor RNA. Levels increased fivefold after 24 hours and greater than sixfold after 48 and 72 hours of exposure to PHA (Fig 4A) .
Half-life of steady-state 1,25(0H),D, receptor RNA is short. We examined the stability of 1,25(OH),D, receptor RNA, using S-LB1 T lymphocytes. These cells were cultured with actinomycin D (5 p,Lg/") for different durations (0 to 8 hours). RNA samples from these cells were analyzed for levels of 1,25(OH),D, receptor RNA (Fig SA, top panel) . Figure 5B summarizes the densitometry readings of the autoradiogram of the Northern blot shown in Fig 5A. The half-life (tl/) of 1,25(OH),D3 receptor RNA was approximately 1 hour.
Inhibition of protein synthesis increases expression of 1,25(0H),D, receptor RNA. Certain RNA species with short tl/ are stabilized by CHX, a protein synthesis inhibitor. 27 We analyzed the role of protein synthesis in regulation of 1,25(OH),D, receptor RNA accumulation. S-LB1 (T lymphocytes) and Lu-CSF-1 (lung adenocarcinoma cells) were exposed to CHX (20 pg/mL) for 4 hours (Fig 6) . Except for B-lymphocyte lines, all of the actively proliferating hematopoietic cells we examined expressed 1,25(OH),D, receptor RNA and protein. The 4.6-kb size of a single RNA transcript was similar to that reported for a human breast cancer cell line and a human intestinal cell line. '3 We showed that the steady-state levels of 1,25(OH),D, receptor RNA were not modulated by exposure to high concentrations of the ligand for 24 to 72 hours. Similarly, glucocorticoid had no effect on the levels of RNA coding for the glucocorticoid receptors in lymphocyte^.^^ Our 1,25(OH),D3 receptor-binding assays showed that the number of occupied 1,25(OH),D3 receptors was increased and the number of unoccupied receptors was decreased by culture with the ligand. The total number of receptors decreased about 50% at 24 hours and then began to return toward baseline at 72 hours of culture with 1,25(OH),D3. These RNA and receptor data suggest that partial regulation of 1,25(OH),D, receptor levels occur posttranscriptionally without alterations in cellular levels of transcripts coding for 1,25(OH),D, receptors. In previous studies, vitamin D, metabolites upregulated the number of 1,25(OH),D, receptors in a porcine kidney cell line (LLCPKl)?' Recently, investigators using an antibody against the 1,25(OH),D3 receptor showed that 1,25(OH),D3 receptors increased at 12 hours and returned toward baseline at 48 and 72 hours when HL-60 cells were cultured with 1,25(OH),D,.36 This discrepancy between our data and theirs is unclear. We used 50-fold more ligand mol/L); this concentration induces maximum differentiation without cytotoxicity. Furthermore, we measured receptor numbers by their ability to bind to ligand as compared with immunoprecipitation of the receptors. These differences in technique may explain differences in results at 24 hours of exposure to ligand. Our later time points (72 hours of exposure to ligand) are not divergent.% Expression of 1,25(OH),D3 receptor RNA in lympho- In contrast to lymphocytes, nondividing, terminally differentiated HL-60 cells and normal macrophages expressed RNA coding for 1,25(OH),D3 receptors. HL-60 cells were cultured with either RA or DMSO and differentiated to granulocytes or cultured with either TPA or 1,25(OH),D3 and differentiated to macrophages (data not shown). In either case, the cells lost proliferative capacity. In addition, human macrophages were not dividing, as reflected by their low 3H-thymidine incorporation in our experiments; nevertheless, these cells expressed abundant 1,25(OH),D3 receptor transcripts. Further studies have shown that activated monocytes express the 1,25(OH),D3 receptor?' We previ-
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ously showed that macrophages activated by y-interferon (y-IFN) can synthesize 1,25(OH),D3 and their synthesis of 1,25(OH),D3 can be controlled by levels of 1,25(OH),D3 in the culture media39-4'; in addition, we showed that 1,25(OH),D3 can control levels of production of y-IFN and other cytokines produced by T 1ymph0cytes.f~ From these findings, we hypothesized that macrophages and activated T lymphocytes might interact in a paracrine fashion using 1,25(OH),D3 and y-IFN as ~igna1s.f~~' Our present data on RNA expression of 1,25(OH),D3 receptors suggest that the proposed interaction is possible.
The t% of RNA coding for 1,25(OH),D3 receptors in T lymphocytes was 1 hour. A similar instability was noted for RNA coding for the glucocorticoid receptors (120 minutes in lymphocytes)" and RA receptors (40 minutes in T Other genes with transiently expressed transcripts such as MYC and FOS also are superinduced by CHX?" suggesting that a negatively regulating &um-acting protein may be modulating levels of 1,25(OH),D3 receptor transcripts.
